Insmed Incorporated
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell INSM and other ETFs, options, and stocks.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
CEOWilliam H. Lewis
CEOWilliam H. Lewis
Employees912
Employees912
HeadquartersBridgewater, New Jersey
HeadquartersBridgewater, New Jersey
Founded1988
Founded1988
Employees912
Employees912
INSM Key Statistics
Market cap14.45B
Market cap14.45B
Price-Earnings ratio-14.54
Price-Earnings ratio-14.54
Dividend yield—
Dividend yield—
Average volume1.75M
Average volume1.75M
High today$82.04
High today$82.04
Low today$80.48
Low today$80.48
Open price$80.98
Open price$80.98
Volume2.49M
Volume2.49M
52 Week high$82.04
52 Week high$82.04
52 Week low$21.92
52 Week low$21.92
INSM News
TipRanks 17h
Insmed: FDA accepts NDA for brensocatibInsmed (INSM) announced that the U.S. FDA has accepted the company’s New Drug Application for brensocatib for patients with non-cystic fibrosis bronchiectasis....
Analyst ratings
100%
of 17 ratingsBuy
100%
Hold
0%
Sell
0%